Literature DB >> 31742878

Autologous Adipose Tissue-Derived Mesenchymal Stem Cells Introduced by Biliary Stents or Local Immersion in Porcine Bile Duct Anastomoses.

Yi Zhang1,2, Ayushman Sharma1, Dong Jin Joo1,3, Erek Nelson1, Anan AbuRmilah1, Bruce P Amiot1, Christen J Boyer4, Jonathan S Alexander4, Nidhi Jalan-Sakrikar5, John Martin6, Roger Moreira7, Shiraj A Chowdhury5, Michele Smart7, Allan B Dietz7, Scott L Nyberg1,8, Julie K Heimbach1,8, Robert C Huebert5,6,8.   

Abstract

Biliary complications (strictures and leaks) represent major limitations in living donor liver transplantation. Mesenchymal stem cells (MSCs) are a promising modality to prevent biliary complications because of immunosuppressive and angiogenic properties. Our goal was to evaluate the safety of adipose-derived MSC delivery to biliary anastomoses in a porcine model. Secondary objectives were defining the optimal method of delivery (intraluminal versus extraluminal) and to investigate MSC engraftment, angiogenesis, and fibrosis. Pigs were divided into 3 groups. Animals underwent adipose collection, MSC isolation, and expansion. Two weeks later, animals underwent bile duct transection, reanastomosis, and stent insertion. Group 1 received plastic stents wrapped in unseeded Vicryl mesh. Group 2 received stents wrapped in MSC-seeded mesh. Group 3 received unwrapped stents with the anastomosis immersed in an MSC suspension. Animals were killed 1 month after stent insertion when cholangiograms and biliary tissue were obtained. Serum was collected for liver biochemistries. Tissue was used for hematoxylin-eosin and trichrome staining and immunohistochemistry for MSC markers (CD44 and CD34) and for a marker of neoangiogenesis (CD31). There were no intraoperative complications. One pig died on postoperative day 3 due to acute cholangitis. All others recovered without complications. Cholangiography demonstrated no biliary leaks and minimal luminal narrowing. Surviving animals exhibited no symptoms, abnormal liver biochemistries, or clinically significant biliary stricturing. Group 3 showed significantly greater CD44 and CD34 staining, indicating MSC engraftment. Fibrosis was reduced at the anastomotic site in group 3 based on trichrome stain. CD31 staining of group 3 was more pronounced, supporting enhanced neoangiogenesis. In conclusion, adipose-derived MSCs were safely applied to biliary anastomoses. MSCs were locally engrafted within the bile duct and may have beneficial effects in terms of fibrosis and angiogenesis.
Copyright © 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 31742878      PMCID: PMC7061488          DOI: 10.1002/lt.25682

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  30 in total

1.  Application of the allogenic mesenchymal stem cells in the therapy of the bladder tuberculosis.

Authors:  Natalia M Yudintceva; Irina O Bogolyubova; Alexandr N Muraviov; Magomed G Sheykhov; Tatiana I Vinogradova; Evgenii G Sokolovich; Igor A Samusenko; Maxim A Shevtsov
Journal:  J Tissue Eng Regen Med       Date:  2017-12-06       Impact factor: 3.963

2.  Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience.

Authors:  Talia B Baker; Michael A Zimmerman; Nathan P Goodrich; Benjamin Samstein; Elizabeth A Pomfret; James J Pomposelli; Brenda W Gillespie; Carl L Berg; Jean C Emond; Robert M Merion
Journal:  Liver Transpl       Date:  2017-12       Impact factor: 5.799

3.  Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.

Authors:  Carl L Berg; Robert M Merion; Tempie H Shearon; Kim M Olthoff; Robert S Brown; Talia B Baker; Gregory T Everson; Johnny C Hong; Norah Terrault; Paul H Hayashi; Robert A Fisher; James E Everhart
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

Review 4.  Systematic review and meta-analysis of studies of biliary reconstruction in adult living donor liver transplantation.

Authors:  Kenneth S H Chok; Chung Mau Lo
Journal:  ANZ J Surg       Date:  2016-11-11       Impact factor: 1.872

Review 5.  Biliary reconstruction, its complications and management of biliary complications after adult liver transplantation: a systematic review of the incidence, risk factors and outcome.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Daijo Hashimoto
Journal:  Transpl Int       Date:  2010-12-10       Impact factor: 3.782

6.  Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study.

Authors:  C E Freise; B W Gillespie; A J Koffron; A S F Lok; T L Pruett; J C Emond; J H Fair; R A Fisher; K M Olthoff; J F Trotter; R M Ghobrial; J E Everhart
Journal:  Am J Transplant       Date:  2008-10-24       Impact factor: 8.086

7.  Increasing xylazine dose-enhanced anesthetic properties of telazol-xylazine combination in swine.

Authors:  J C Ko; B L Williams; E R Rogers; L S Pablo; W C McCaine; C J McGrath
Journal:  Lab Anim Sci       Date:  1995-06

8.  Long-term follow-up study of biliary reconstructions and complications after adult living donor liver transplantation: feasibility of duct-to-duct reconstruction with a T-tube stent.

Authors:  T Kobayashi; Y Sato; S Yamamoto; H Oya; Y Hara; T Watanabe; H Kokai; K Hatakeyama
Journal:  Transplant Proc       Date:  2009 Jan-Feb       Impact factor: 1.066

Review 9.  The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential.

Authors:  Suzanne M Watt; Francesca Gullo; Mark van der Garde; Daniel Markeson; Rosalba Camicia; Cheen P Khoo; Jaap Jan Zwaginga
Journal:  Br Med Bull       Date:  2013-10-23       Impact factor: 4.291

10.  Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation.

Authors:  Dong Han; Xiang Li; Wen-Si Fan; Jiang-Wei Chen; Tian-Tian Gou; Tao Su; Miao-Miao Fan; Meng-Qi Xu; Ya-Bin Wang; Sai Ma; Ya Qiu; Feng Cao
Journal:  Oncotarget       Date:  2017-05-04
View more
  1 in total

1.  Stem cell therapy applied for digestive anastomosis: Current state and future perspectives.

Authors:  Jacobo Trébol; Tihomir Georgiev-Hristov; Isabel Pascual-Miguelañez; Hector Guadalajara; Mariano García-Arranz; Damian García-Olmo
Journal:  World J Stem Cells       Date:  2022-01-26       Impact factor: 5.326

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.